This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Siess, W. Articles by Weber, P. C. Search for Related Content PubMed PubMed Citation Articles by Siess, W. Articles by Weber, P. C.

Circulation, Vol 66, 44-48, Copyright © 1982 by American Heart Association

ARTICLES

Plasma catecholamines, platelet aggregation and associated thromboxane formation after physical exercise, smoking or norepinephrine infusion

W Siess, R Lorenz, P Roth and PC Weber

To study the possible role of catecholamines in platelet activation, platelet aggregation stimulated by ADP, collagen, arachidonic acid and L-epinephrine, thromboxane B2 (TXB2) formation and plasma levels of catecholamines and renin were studied in healthy men both before and after 6 days of propranolol treatment (40 mg three times daily) under control conditions and during sympathoadrenergic stimulation by physical exercise (200 W) or smoking. Exercise markedly increased plasma norepinephrine from 128 +/- 28 to 998 +/- 418 pg/ml (+/- SD), and plasma renin activity from 1.0 +/- 0.5 to 4.2 +/- 1.8 ng AI/ml . hour. Smoking predominantly increased plasma epinephrine, from 47 +/- 25 to 154 +/- 76 pg/ml. Propranolol did not consistently influence these variables, but blunted the circulatory response to exercise and smoking. Despite the marked increases of plasma catecholamines after both stimuli with and without beta blockade, platelet aggregation stimulated by ADP, 1-epinephrine, collagen and arachidonic acid and associated TXB2 formation were not enhanced. Moreover, as already suggested by a trend toward reduced aggregability in these settings, plasma norepinephrine levels in the same range (745 +/- 368 pg/ml) due to infusion (5 micrograms/min) significantly reduced platelet aggregation with low-dose collagen (0.25-0.75 micrograms/ml), I- epinephrine (0.2-1.0 microM) and ADP (0.5-1.5 microM). These data do not support a role of endogenous catecholamines in initiating platelet activation and TXB2 formation.

This article has been cited by other articles:

				A. Coppola, L. Coppola, L. dalla Mora, F. M. Limongelli, A. Grassia, L. Mastrolorenzo, G. Gombos, and G. Lucivero Vigorous exercise acutely changes platelet and B-lymphocyte CD39 expression J Appl Physiol, April 1, 2005; 98(4): 1414 - 1419. [Abstract] [Full Text] [PDF]

				C. J. Smith, T. H. Fischer, D. L. Heavner, M. A. Rumple, D. L. Bowman, B. G. Brown, M. J. Morton, and D. J. Doolittle Urinary Thromboxane, Prostacyclin, Cortisol, and 8-Hydroxy-2'-deoxyguanosine in Nonsmokers Exposed and Not Exposed to Environmental Tobacco Smoke Toxicol. Sci., February 1, 2001; 59(2): 316 - 323. [Abstract] [Full Text] [PDF]

				H. Hioki, N. Aoki, K. Kawano, M. Homori, Y. Hasumura, T. Yasumura, A. Maki, H. Yoshino, A. Yanagisawa, and K. Ishikawa Acute effects of cigarette smoking on platelet-dependent thrombin generation Eur. Heart J., January 1, 2001; 22(1): 56 - 61. [Abstract] [PDF]

				K. Eto, S. Takeshita, M. Ochiai, Y. Ozaki, T. Sato, and T. Isshiki Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability Cardiovasc Res, October 1, 1998; 40(1): 223 - 229. [Abstract] [Full Text] [PDF]

				D. S. Krantz, W. J. Kop, F. H. Gabbay, A. Rozanski, M. Barnard, J. Klein, Y. Pardo, and J. S. Gottdiener Circadian Variation of Ambulatory Myocardial Ischemia : Triggering by Daily Activities and Evidence for an Endogenous Circadian Component Circulation, April 1, 1996; 93(7): 1364 - 1371. [Abstract] [Full Text]

				J. Hung, J. Y.T. Lam, L. Lacoste, and G. Letchacovski Cigarette Smoking Acutely Increases Platelet Thrombus Formation in Patients With Coronary Artery Disease Taking Aspirin Circulation, November 1, 1995; 92(9): 2432 - 2436. [Abstract] [Full Text]

				S. E. Kjeldsen, A. B. Weder, B. Egan, R. Neubig, A. J. Zweifler, and S. Julius Effect of Circulating Epinephrine on Platelet Function and Hematocrit Hypertension, May 1, 1995; 25(5): 1096 - 1105. [Abstract] [Full Text]

				H. Lin and D. B. Young Opposing Effects of Plasma Epinephrine and Norepinephrine on Coronary Thrombosis In Vivo Circulation, February 15, 1995; 91(4): 1135 - 1142. [Abstract] [Full Text]